Depression and bone mineral density in a community sample of perimenopausal women: Geelong Osteoporosis Study
- 1 January 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Menopause
- Vol. 12 (1) , 88-91
- https://doi.org/10.1097/00042192-200512010-00015
Abstract
Objective: Reduced bone mineral density (BMD) in women with a history of depressive disorders has been shown in some, but not all studies. This study investigated the association between self-reported depression and BMD in an age-stratified community sample of perimenopausal women residing in the South-Eastern region of Australia. Design: Symptoms of depression in the year between July 2000 and July 2001 were ascertained by a self-report questionnaire based on Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) criteria. Women in the perimenopausal group who had undergone a BMD total hip and spine assessment within the 12-month period after the depression assessment were included in the analysis, resulting in a sample of 78 women aged 45 to 60 years. Results: In this sample, 14 women were identified as depressed. There was no difference in age, hormone therapy (HT) use, or unadjusted BMD at the total hip or spine between the depressed and nondepressed women (P = 0.14, 0.89, 0.57, and 0.70, respectively), but the depressed women tended to be heavier [depressed (median weight, interquartile range = 80 kg, 66-94) vs nondepressed (72 kg, 61-80) P = 0.06]. Whereas there was no significant difference in age-, HT-, and weight-adjusted BMD at the spine [depressed (mean ± SE = 1.21 ± 0.05) vs nondepressed (1.28 ± 0.03 g/cm2) P = 0.18], adjusted BMD at the total hip for the depressed women was 7.8% lower than for the nondepressed [depressed (mean ± SE = 0.957 ± 0.038) vs nondepressed (1.038 ± 0.023 g/cm2) P = 0.04]. Conclusions: These results suggest that in perimenopausal women, self-reported depression is associated with lower BMD at the hip.Keywords
This publication has 22 references indexed in Scilit:
- Evidence that type I osteoporosis results from enhanced responsiveness of bone to estrogen deficiencyOsteoporosis International, 2003
- Estrogens and Bone Health in MenCalcified Tissue International, 2001
- Prevalence of Osteoporosis in Australian WomenJournal of Clinical Densitometry, 2000
- Glucocorticoid-induced osteoporosisBest Practice & Research Clinical Endocrinology & Metabolism, 2000
- Glucocorticoid-induced osteoporosis: a cross-sectional studySteroids, 1991
- The assessment of abnormalities in hormonal responsiveness at multiple levels of the hypothalamic-pituitary-adrenocortical axis in depressive illnessPsychoneuroendocrinology, 1989
- The ACTH stimulation test before and after clinical recovery from depressionPsychiatry Research, 1987
- Clinical studies with corticotropin releasing factor: implications for the diagnosis and pathophysiology of depression, Cushing's disease, and adrenal insufficiencyPsychoneuroendocrinology, 1985
- Steroid-Induced Fractures and Bone Loss in Patients with AsthmaNew England Journal of Medicine, 1983
- Differential effects of endocrine dysfunction on the axial and the appendicular skeleton.Journal of Clinical Investigation, 1982